CD28 and nonpapillary renal cell carcinoma: The results obtained in the in vivo orthotopic ccRCC model showed that anti-CAIX CAR T cells that release anti-PD-L1 promoted a significant reduction in tumor volume and weight, with the construction with CD28 showing more potent results compared to 4-1BB, preventing the induction of tumor metastases.